CDKN2A and adenocarcinoma: Their results showed two hypomethylated genes (CDKN2A and MGMT) and three hypermethylated genes (CDH13, RUNX3, APC) in adenocarcinomas compared with SCC, with the higher sensitivity and specificity values of CDH13 and APC [24].